Mother's Voice Therapy for Premature Birth
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if recordings of a mother's voice can promote healthy brain and language development in preterm infants. Babies in the study will either listen to their mother's voice daily (Language Treatment) or receive standard care without the recordings (Control Treatment). The trial is designed for preterm infants born between 24 and 31 weeks at Stanford Children's Hospital, excluding those with certain medical conditions like major hearing loss or active seizures.
As an unphased trial, this study provides a unique opportunity to contribute to groundbreaking research that could enhance early developmental care for preterm infants.
Will I have to stop taking my current medications?
The trial information does not specify whether participants need to stop taking their current medications.
What prior data suggests that playing a mother's voice is safe for infants?
Research has shown that listening to a mother's voice is generally safe for premature babies. It helps maintain a steady heart rate and supports weight gain, indicating good tolerance. Other studies have found that playing recordings of a mother's voice can enhance brain development in premature babies. Although results have varied regarding effects on areas like feeding and cognitive skills, no major safety concerns have been reported. Overall, mother's voice therapy appears to be a safe option for these infants.12345
Why are researchers excited about this trial?
Researchers are excited about the Mother's Voice Therapy because it takes a unique approach to supporting premature infants. Unlike traditional treatments that focus on medical interventions and environmental modifications, this therapy uses recordings of a mother's voice to potentially enhance language and cognitive development. The therapy is non-invasive, aiming to create a comforting and familiar auditory environment that might help with brain development at a critical time. By leveraging the natural bond between mother and child, this method could offer a simple yet powerful tool to improve outcomes for premature babies.
What evidence suggests that playing a mother's voice is effective for promoting brain and language development in preterm infants?
This trial will compare the effects of playing recordings of a mother's voice with standard care for premature infants. Studies have shown that hearing a mother's voice aids in developing language skills in a premature baby's brain. Research indicates that listening to a mother's voice can stabilize preterm infants by improving heart rate and reducing breathing problems. Babies who hear their mother's voice also tend to develop better language skills. Additionally, a mother's voice can reduce pain and improve body functions in newborns. These findings suggest that playing recordings of a mother's voice could support healthy brain and language development in preterm infants.14567
Who Is on the Research Team?
Katherine E Travis, PhD
Principal Investigator
Stanford University
Are You a Good Fit for This Trial?
This trial is for premature infants born at Stanford Children's Hospital between 24 and nearly 32 weeks of gestation. It excludes those with congenital anomalies, seizure disorders, severe brain injuries like grade III-IV hemorrhages or cystic PVL, major hearing loss, or conditions requiring transfer before reaching 36 weeks post-menstrual age.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Infants are played recordings of their mother's voice 2-3 hours daily in the intermediate care nursery until discharge
Follow-up
Participants are monitored for long-term impacts on brain and language development, including MRI scans and language assessments
What Are the Treatments Tested in This Trial?
Interventions
- Control Treatment
- Language Treatment
Find a Clinic Near You
Who Is Running the Clinical Trial?
Stanford University
Lead Sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Collaborator